389 related articles for article (PubMed ID: 18824769)
21. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning.
Flanagan TC; Cornelissen C; Koch S; Tschoeke B; Sachweh JS; Schmitz-Rode T; Jockenhoevel S
Biomaterials; 2007 Aug; 28(23):3388-97. PubMed ID: 17467792
[TBL] [Abstract][Full Text] [Related]
22. A self-renewing, tissue-engineered vascular graft for arterial reconstruction.
Torikai K; Ichikawa H; Hirakawa K; Matsumiya G; Kuratani T; Iwai S; Saito A; Kawaguchi N; Matsuura N; Sawa Y
J Thorac Cardiovasc Surg; 2008 Jul; 136(1):37-45, 45.e1. PubMed ID: 18603051
[TBL] [Abstract][Full Text] [Related]
23. Physiologic pulsatile flow bioreactor conditioning of poly(ethylene glycol)-based tissue engineered vascular grafts.
Hahn MS; McHale MK; Wang E; Schmedlen RH; West JL
Ann Biomed Eng; 2007 Feb; 35(2):190-200. PubMed ID: 17180465
[TBL] [Abstract][Full Text] [Related]
24. Perfusion bioreactor for small diameter tissue-engineered arteries.
Williams C; Wick TM
Tissue Eng; 2004; 10(5-6):930-41. PubMed ID: 15265311
[TBL] [Abstract][Full Text] [Related]
25. [Experimental study on tissue engineered blood vessel reconstruction with bionanotechnology].
Zheng X; Qiao T; Ran F; Liu C
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2008 Jan; 22(1):92-6. PubMed ID: 18361248
[TBL] [Abstract][Full Text] [Related]
26. Development of a composite degradable/nondegradable tissue-engineered vascular graft.
Tschoeke B; Flanagan TC; Cornelissen A; Koch S; Roehl A; Sriharwoko M; Sachweh JS; Gries T; Schmitz-Rode T; Jockenhoevel S
Artif Organs; 2008 Oct; 32(10):800-9. PubMed ID: 18684200
[TBL] [Abstract][Full Text] [Related]
27. A low-flow adaptation phase improves shear-stress resistance of artificially seeded endothelial cells.
Gulbins H; Pritisanac A; Petzold R; Goldemund A; Doser M; Dauner M; Meiser B; Reichart B; Daebritz S
Thorac Cardiovasc Surg; 2005 Apr; 53(2):96-102. PubMed ID: 15786008
[TBL] [Abstract][Full Text] [Related]
28. Seeding of human vascular cells onto small diameter polyurethane vascular grafts.
Gulbins H; Pritisanac A; Dauner M; Petzold R; Goldemund A; Doser M; Meiser B; Reichart B
Thorac Cardiovasc Surg; 2006 Mar; 54(2):102-7. PubMed ID: 16541350
[TBL] [Abstract][Full Text] [Related]
29. Tissue-engineered vessel strengthens quickly under physiological deformation: application of a new perfusion bioreactor with machine vision.
Xu J; Ge H; Zhou X; Yang D; Guo T; He J; Li Q; Hao Z
J Vasc Res; 2005; 42(6):503-8. PubMed ID: 16155366
[TBL] [Abstract][Full Text] [Related]
30. A novel single-step self-assembly approach for the fabrication of tissue-engineered vascular constructs.
Gauvin R; Ahsan T; Larouche D; Lévesque P; Dubé J; Auger FA; Nerem RM; Germain L
Tissue Eng Part A; 2010 May; 16(5):1737-47. PubMed ID: 20038201
[TBL] [Abstract][Full Text] [Related]
31. Development of anti-atherosclerotic tissue-engineered blood vessel by A20-regulated endothelial progenitor cells seeding decellularized vascular matrix.
Zhu C; Ying D; Mi J; Li L; Zeng W; Hou C; Sun J; Yuan W; Wen C; Zhang W
Biomaterials; 2008 Jun; 29(17):2628-36. PubMed ID: 18377984
[TBL] [Abstract][Full Text] [Related]
32. A novel concept for scaffold-free vessel tissue engineering: self-assembly of microtissue building blocks.
Kelm JM; Lorber V; Snedeker JG; Schmidt D; Broggini-Tenzer A; Weisstanner M; Odermatt B; Mol A; Zünd G; Hoerstrup SP
J Biotechnol; 2010 Jul; 148(1):46-55. PubMed ID: 20223267
[TBL] [Abstract][Full Text] [Related]
33. Decellularized native and engineered arterial scaffolds for transplantation.
Dahl SL; Koh J; Prabhakar V; Niklason LE
Cell Transplant; 2003; 12(6):659-66. PubMed ID: 14579934
[TBL] [Abstract][Full Text] [Related]
34. Viability of engineered vessels as arterial substitutes.
García-Honduvilla N; Domínguez B; Pascual G; Escudero C; Minguela F; Bellón JM; Buján J
Ann Vasc Surg; 2008 Mar; 22(2):255-65. PubMed ID: 18346580
[TBL] [Abstract][Full Text] [Related]
35. Development of endothelium-denuded human umbilical veins as living scaffolds for tissue-engineered small-calibre vascular grafts.
Hoenicka M; Schrammel S; Bursa J; Huber G; Bronger H; Schmid C; Birnbaum DE
J Tissue Eng Regen Med; 2013 Apr; 7(4):324-36. PubMed ID: 22689499
[TBL] [Abstract][Full Text] [Related]
36. Bioreactor-induced mesenchymal progenitor cell differentiation and elastic fiber assembly in engineered vascular tissues.
Lin S; Mequanint K
Acta Biomater; 2017 Sep; 59():200-209. PubMed ID: 28690007
[TBL] [Abstract][Full Text] [Related]
37. Porcine small diameter arterial extracellular matrix supports endothelium formation and media remodeling forming a promising vascular engineered biograft.
Dahan N; Zarbiv G; Sarig U; Karram T; Hoffman A; Machluf M
Tissue Eng Part A; 2012 Feb; 18(3-4):411-22. PubMed ID: 21919798
[TBL] [Abstract][Full Text] [Related]
38. Engineering biological-based vascular grafts using a pulsatile bioreactor.
Huang AH; Niklason LE
J Vis Exp; 2011 Jun; (52):. PubMed ID: 21694696
[TBL] [Abstract][Full Text] [Related]
39. Living patches engineered from human umbilical cord derived fibroblasts and endothelial progenitor cells.
Schmidt D; Mol A; Neuenschwander S; Breymann C; Gössi M; Zund G; Turina M; Hoerstrup SP
Eur J Cardiothorac Surg; 2005 May; 27(5):795-800. PubMed ID: 15848316
[TBL] [Abstract][Full Text] [Related]
40. Production of extracellular matrix components in tissue-engineered blood vessels.
Heydarkhan-Hagvall S; Esguerra M; Helenius G; Söderberg R; Johansson BR; Risberg B
Tissue Eng; 2006 Apr; 12(4):831-42. PubMed ID: 16674296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
